Oesophagus Barrettiensis

Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.

Oesophagus Barrettiensis (ICD-10: K22.7) est metaplasia epithelii oesophagi et conditio praemaligna, quae ex oesophagite propter refluctionem orta est^[1] et simul transformatio reversibilis cellularum videtur, quamquam in parte in adenocarcinomam transeat. Diagnosis et therapiae endoscopium adhibetur^[2].

Symptomata et signa

Vicissitudo qualitatum cellularum de normalis ad praemalignas, oeseophagum Barrettiensem indicans, aliqua symptomata specificata non concitent, quamquam quibusdam cum sequentibus suspicio excitetur:

Pyrosis frequens ac manens
Dysphagia — difficultas devorandi
Haematemesis — sanguinem vomitans
Dolor sub sternum (quo oesophagus stomachum tangunt)
Odynophagia — edere dolorem efficiens, igitur pondus amittens involuntaria

At similius oesophagum Barrettiensem capi cum obesitate abdominali (vs. obesitate peripherico)^[3]. Machinatio autem eius exacta dubia est.

Nexus interni

Notae

↑ Shaheen NJ, Richter JE (2009). "Barrett's oesophagus". Lancet 373 (9666): 850-61
↑ Mansour NM, El-Serag HB, Anandasabapathy S (2017). "Barrett's esophagus: best practices for treatment and post-treatment surveillance". Ann Cardiothorac Surg 6 (2): 75-87
↑ Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL (2007). "Central adiposity and risk of Barrett esophagus". Gastroenterology 133 (2): 403–11

Nexus externi

LGA de oesophago Barrettiensi. (Anglice)

[1] Shaheen NJ, Richter JE (2009). "Barrett's oesophagus". Lancet 373 (9666): 850-61

[2] Mansour NM, El-Serag HB, Anandasabapathy S (2017). "Barrett's esophagus: best practices for treatment and post-treatment surveillance". Ann Cardiothorac Surg 6 (2): 75-87

[3] Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL (2007). "Central adiposity and risk of Barrett esophagus". Gastroenterology 133 (2): 403–11

[1]

[2]

[3]